YXX-17043-65076
2 vaccinations
4 coded responses
16 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 485 / MI
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-18
Survey response — day 0, dose 1MedDRA: Blood glucose increased — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Increased Blood SugarMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 1MedDRA: Blood glucose increased, Heart rate increased, Hypotension — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Rapid heart rate, low blood presssure, increased blood sugar without other known cause.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-27
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
-
2021-09-16
Survey response — 6 months, dose 1MedDRA: Oropharyngeal pain, Productive cough, Rhinorrhoea — Feeling: FairFree text: Runny nose, productive cough, sore throat.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Dose 2 — ModernaCo-administered: Flu
- 2021-11-03
- 2021-11-12
- 2021-11-17
- 2021-12-01
-
2022-01-28
Survey response — 3 months, dose 2MedDRA: Fatigue, Headache, Nausea, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Runny nose, headache, nausea, fatigue.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-27 | Moderna | Flu |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Increased Blood Sugar
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Rapid heart rate, low blood presssure, increased blood sugar without other known cause.
Release 9 — 6 months, dose 1
Symptoms: Runny nose, productive cough, sore throat.
Release 11 — 3 months, dose 2
Symptoms: Runny nose, headache, nausea, fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Hypotension | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release